Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check3 days agoChange DetectedLocation labels updated from Vienna to State of Vienna, with the address now shown as Vienna, State of Vienna, Austria, 1090 (replacing Vienna, Vienna, Austria, 1090); revision bumped from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAbbotsford, British Columbia, Canada, V2T 1X8 entry was reformatted to Abbotsford British Columbia, British Columbia, Canada, V2T 1X8 in the location list.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. There are no visible changes to the Study Details content or its functionality.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2. No visible changes to page content or layout.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.